Scientists Decry Axing EU Head Scientist Post

Researchers in Europe are universally dismayed over the decision to eliminate the European Commission’s Chief Scientific Advisor role.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Anne Glover, former Chief Scientific Advisor to the European CommissionWIKIMEDIA, FRIENDS OF EUROPEThe European Commission (EC) decided to retire the position of Chief Scientific Advisor (CSA) last month (October 31), and researchers across Europe are upset with the move. The incoming EC administration decided to do away with the post, which has been filled by molecular biologist Anne Glover of the University of Aberdeen since its inception in 2012, as it came to power at the beginning of this month (November 1).

“Scientific advice must be central to EU policy making, otherwise you run the risk of having important decisions being unduly influenced by those with mixed motives,” the Royal Society’s Paul Nurse told BBC News. “If the Commission has a plausible plan for ensuring that scientific evidence will be taken seriously they need to start sharing it with people soon, otherwise they will encourage those who portray the Commission as out of touch and not willing to listen to informed advice.”

Nigel Brown, president of the Society for General Microbiology, echoed Nurse’s dismay. “I am appalled at the abolition of the CSA post,” he told BBC News. “Many of the major challenges facing Europe—climate change, food security, healthy ageing, disease control—require scientific input to policy at ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies